UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
February 15, 2024 4:30 P.M.
Form:
F-1
CIK:
0001553846
Company Name:
RedHill Biopharma Ltd.
File Number:
333-276979